RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shyamali Mukherjee to 9,10-Dimethyl-1,2-benzanthracene

This is a "connection" page, showing publications Shyamali Mukherjee has written about 9,10-Dimethyl-1,2-benzanthracene.
  1. Mukherjee S, Mohammad AR, Das SK. Effects of dimethylbenz[a]anthracene-induced malignancy on the subcellular distribution of peripheral benzodiazepine receptors in submandibular glands of rats. Biochem Pharmacol. 1990 Oct 01; 40(7):1589-94.
    View in: PubMed
    Score: 0.093
  2. Mukhopadhyay S, Mukherjee S, Das SK. Increased expression of peripheral benzodiazepine receptor (PBR) in dimethylbenz[a]anthracene-induced mammary tumors in rats. Glycoconj J. 2006 May; 23(3-4):199-207.
    View in: PubMed
    Score: 0.069
  3. Mukhopadhyay S, Guillory B, Mukherjee S, Das SK. Antiproliferative effect of peripheral benzodiazepine receptor antagonist PK11195 in rat mammary tumor cells. Mol Cell Biochem. 2010 Jul; 340(1-2):203-13.
    View in: PubMed
    Score: 0.022
  4. Sinha Roy S, Mukhopadhyay S, Mukherjee S, Das SK. Breast cancer is associated with an increase in the activity and expression of cholinephosphotransferase in rats. Life Sci. 2008 Nov 07; 83(19-20):661-5.
    View in: PubMed
    Score: 0.020
  5. Mukhopadhyay S, Rajaratnam V, Mukherjee S, Das SK. Control of peripheral benzodiazepine receptor-mediated breast cancer in rats by soy protein. Mol Carcinog. 2008 Apr; 47(4):310-9.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support